The GLP is committed to full transparency. Download and review our 2019 Annual Report

Australia glyphosate-cancer class action lawsuit gets underway

This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

The first directions hearing in a class action against chemical giant Monsanto, over claims commonly used herbicide Roundup causes cancer, have been held in the Federal Court [Dec. 19].

In the US, Monsanto was ordered to pay out hundreds of millions of dollars in damages to four cancer patients, with thousands more plaintiffs awaiting trial.

The lawyers representing the class action allege Monsanto misled consumers by suggesting the active ingredient in Roundup, glyphosate, was safe and did not pose a health risk to humans who followed the company’s product safety directions.

Monsanto has repeatedly argued the science says glyphosate is safe, as do regulators across the world.

Related article:  As Chipotle struggles with poisoning crisis, it's under fire for GMO and sustainability claims

LHD Lawyers managing director Matthew Berenger said they would also allege Monsanto breached consumer product safety guarantee provisions in the Australian Consumer Law.

Read full, original article: Monsanto Roundup class action underway in Federal Court

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend